Venus Concept Announces CE Mark for Venus Versa™ Pro in Europe
TORONTO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received the CE Mark from DEKRA Certification B.V. to market the Venus Versa Pro system in the European Union. This follows the Company’s announcement on November 1, 2023 regarding the commercial launch of the device in the United States.
The Venus Versa Pro incorporates Venus Concept’s latest advancements in fractional skin resurfacing, enabling enhanced ablation and coagulation to achieve optimal results when treating a wide range of skin conditions including acne scars, skin texture, and stretch marks. It also provides customers in the European Union the ability to incorporate these advancements into unique protocols like “Tribella”, offering a complete skin rejuvenation solution.
“Receiving the CE Mark for Venus Versa Pro reflects our continued commitment to bringing our latest and most innovative products to the international aesthetic markets in parallel with our restructuring efforts,” said Dr. Hemanth Varghese, President and Chief Operating Officer of Venus Concept. “Venus Versa Pro builds on the successful Venus Versa system, with over 2,200 systems installed globally. It is a multi-modal system that incorporates the breadth of Venus Concept’s technologies for clinicians to address the growing needs of the European customer.”
